Get started
Author

Robert Tarrel

Observed name: R. Tarrel
Observed institution: Mayo Clinic
OpenAlex ID: A5004122099
Eligibility for neoadjuvant/adjuvant cisplatin‐based chemotherapy among radical cystectomy patients
2013 · R. Houston Thompson, Stephen A. Boorjian, et al. · British Journal of Urology · 78
Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience
2019 · Luca Boeri, Matteo Soligo, et al. · World Journal of Urology · 11
1294 Eligibility for Neoadjuvant/adjuvant Cisplatin-based Chemotherapy Among Radical Cystectomy Patients
2013 · R. Houston Thompson, Stephen Boorjian, et al. · The Journal of Urology · 8
Ip56-21 Computer Vision-based Body Composition Biometrics Is Associated With Early Complications After Nephroureterectomy
2026 · Ranveer M. S. Vasdev, Garrett Ungerer, et al. · The Journal of Urology
75 Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients
2013 · R.H. Thompson, S.A. Boorjian, et al. · European Urology Supplements
Works count: 5
Citation count: 97
H-index: 3
I10-index: 2
Year
Topic
Type